Corona Remedies acquires 7 brands from Bayer's pharma division in India
This marks the fourth acquisition by Corona Remedies from multinational corporations
This marks the fourth acquisition by Corona Remedies from multinational corporations
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
Our centers are performing as expected or even better
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Leading USA based genetic testing brand officially enters the Indian market
Subscribe To Our Newsletter & Stay Updated